Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 1998216-00-4 | MDL No. : | MFCD30187530 |
Formula : | C11H15ClN2O2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | WUIPIWUUGYGNDI-UHFFFAOYSA-N |
M.W : | 242.70 g/mol | Pubchem ID : | 122173515 |
Synonyms : |
|
Num. heavy atoms : | 16 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.36 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 2.0 |
Molar Refractivity : | 71.72 |
TPSA : | 52.57 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | Yes |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -8.11 cm/s |
Log Po/w (iLOGP) : | 0.0 |
Log Po/w (XLOGP3) : | -0.47 |
Log Po/w (WLOGP) : | 0.83 |
Log Po/w (MLOGP) : | 1.27 |
Log Po/w (SILICOS-IT) : | 0.99 |
Consensus Log Po/w : | 0.53 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.19 |
Solubility : | 15.5 mg/ml ; 0.064 mol/l |
Class : | Very soluble |
Log S (Ali) : | -0.17 |
Solubility : | 165.0 mg/ml ; 0.68 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -2.27 |
Solubility : | 1.29 mg/ml ; 0.00532 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.69 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
![]() |
[ 86620-62-4 ]
4-(4-Methylpiperazin-1-yl)benzoic acid
Similarity: 0.96
[ 215309-01-6 ]
3-(4-Methylpiperazin-1-yl)benzoic acid
Similarity: 0.96
[ 118996-38-6 ]
4,4',4''-Nitrilotribenzoic acid
Similarity: 0.91
[ 86620-62-4 ]
4-(4-Methylpiperazin-1-yl)benzoic acid
Similarity: 0.96
[ 215309-01-6 ]
3-(4-Methylpiperazin-1-yl)benzoic acid
Similarity: 0.96
[ 118996-38-6 ]
4,4',4''-Nitrilotribenzoic acid
Similarity: 0.91
[ 86620-62-4 ]
4-(4-Methylpiperazin-1-yl)benzoic acid
Similarity: 0.96
[ 215309-01-6 ]
3-(4-Methylpiperazin-1-yl)benzoic acid
Similarity: 0.96
[ 26586-27-6 ]
3-Amino-4-(piperidin-1-yl)benzoic acid
Similarity: 0.87
[ 72548-79-9 ]
3-(Pyrrolidin-1-yl)benzoic acid
Similarity: 0.87
[ 86620-62-4 ]
4-(4-Methylpiperazin-1-yl)benzoic acid
Similarity: 0.96
[ 215309-01-6 ]
3-(4-Methylpiperazin-1-yl)benzoic acid
Similarity: 0.96
[ 159974-63-7 ]
Methyl 2-(piperazin-1-yl)benzoate
Similarity: 0.81
[ 123987-13-3 ]
(3-(4-Methylpiperazin-1-yl)phenyl)methanol
Similarity: 0.77
[ 106261-49-8 ]
4-[(4-Methylpiperazin-1-yl)methyl]benzoic acid dihydrochloride
Similarity: 0.77